Expert Review of Neurotherapeutics (ISSN 1473-7175) provides expert reviews on the use of drugs and medicines in clinical neurology and neuropsychiatry. Coverage includes disease management, new medicines and drugs in neurology, therapeutic indications, diagnostics, medical treatment guidelines and neurological diseases such as stroke, epilepsy, Alzheimer's and Parkinson's. Comprehensive coverage in each review is complemented by the unique Expert Review format and includes the following sections: Expert Opinion - a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed resultsArticle Highlights – an executive summary of the author’s most critical points
神经治疗学专家评论（ISSN 1473-7175）提供了关于临床神经病学和神经精神病学中药物和药物使用的专家评论。覆盖范围包括疾病管理、新药物和神经病学药物、治疗适应症、诊断、医疗指南以及中风、癫痫、阿尔茨海默氏症和帕金森氏症等神经疾病。每项审查的全面覆盖范围由独特的专家审查格式补充，包括以下部分：专家意见--对文章中数据的个人观点，对未来可能重要的发展的讨论，以及随着进一步研究产生更详细的结果而可能变得令人兴奋的研究途径文章亮点--作者最关键观点的执行摘要
Gut microbiota in ALS: possible role in pathogenesis?
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1623026
Biomarkers for bipolar disorder: current status and challenges ahead
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1550361
Multidisciplinary care for people with Parkinson’s disease: the new kids on the block!
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1561285
Intracerebral hemorrhage: an update on diagnosis and treatment
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1623671
Fremanezumab as a preventive treatment for episodic and chronic migraine
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1614742
The role of polytherapy in the management of epilepsy: suggestions for rational antiepileptic drug selection
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2020.1707668
Disease-modifying therapies for tauopathies: agents in the pipeline
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1606715
Stiripentol for the treatment of seizures associated with Dravet syndrome
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1593142
Evidence-based treatment of Tourette’s disorder and chronic tic disorders
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1643236
Contemporary management of the pseudotumor cerebri syndrome
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1660163
Everolimus as adjunctive therapy for tuberous sclerosis complex-associated partial-onset seizures
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1635457
Traditional Ayurvedic and herbal remedies for Alzheimer’s disease: from bench to bedside
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1596803
Beyond stimulants: a systematic review of randomised controlled trials assessing novel compounds for ADHD
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1628640
Cortico-limbic connectivity as a possible biomarker for bipolar disorder: where are we now?
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1562338
Therapeutic strategies for social anxiety disorder: where are we now?
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1666713
Antihypertensive agents in Alzheimer’s disease: beyond vascular protection
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2020.1708195
Timing use of novel anti-epileptic drugs: is earlier better?
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1636649
Emerging therapies in Huntington’s disease
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1631161
Glial cells as therapeutic targets in progressive multiple sclerosis
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1614443
The use of new psychoactive substances (NPS) in young people and their role in mental health care: a systematic review
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1666712
Neuromodulation for the treatment of primary headache syndromes
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1585243
Paroxysmal movement disorders – practical update on diagnosis and management
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1648211
Taurine and GABA neurotransmitter receptors, a relationship with therapeutic potential?
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1593827
An update on thymectomy in myasthenia gravis
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1600404
Potential effects of nicotine on glioblastoma and chemoradiotherapy: a review
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1617701
An update on clinical, pathological, diagnostic, and therapeutic perspectives of childhood leukodystrophies
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2020.1699060
Cariprazine for the treatment of bipolar depression: a review
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1580571
An update on EEG in migraine
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1586534
Extended-Release Amantadine for Levodopa-Induced Dyskinesia
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1592677
Imaging in the diagnosis of idiopathic inflammatory myopathies; indications and utility
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1572507
Cognitive remediation therapy of working memory in addictive disorders: An individualized, tailored, and recovery-oriented approach
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1591950
Parkinson’s disease management and impulse control disorders: current state and future perspectives
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1620603
Controversies in the management of neuromyelitis optica spectrum disorder
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1648210
Discriminating schizophrenia disease progression using a P50 sensory gating task with dense-array EEG, clinical assessments, and cognitive tests
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1601558
Sensory-targeted cognitive training for schizophrenia
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1581609
An update on neurocritical care for intracerebral hemorrhage
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1618709
Advantages and limitations of amino acid PET for tracking therapy response in glioma patients
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2020.1704256
Intravenous immunoglobulins for Alzheimer’s disease and mild cognitive impairment due to Alzheimer’s disease: A systematic review with meta-analysis
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1620106
Gut microbiota and psychogenic non-epileptic seizures: i can feel it in the belly
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1684901
Approaching drug-induced parkinsonism from a neurohospitalist perspective
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1569515
Current and future clinical utilities of Parkinson’s disease and dementia biomarkers: can they help us conquer the disease?
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1649141
How can an understanding of the C9orf72 gene translate into amyotrophic lateral sclerosis therapies?
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1635884
Treatment of psychiatric disturbances in hypokinetic movement disorders
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1636648
Reversing the myth of phase reversals
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2020.1696193
Modification of CSF findings in multiple sclerosis in the era of rapidly expanding treatment options
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1583557
Hereditary spastic paraplegias: time for an objective case definition and a new nosology for neurogenetic disorders to facilitate biomarker/therapeutic studies
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1608824
Dasotraline in ADHD: novel or me too drug?
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1593826
Treatment options for tic disorders
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2020.1698950
Shedding light on migraine with aura: the clarifying role of advanced neuroimaging investigations
来源期刊：Expert Review of NeurotherapeuticsDOI：10.1080/14737175.2019.1638252
